Urogen Pharma's total assets for Q3 2025 were $185.05M, a decrease of -11.34% from the previous quarter. URGN total liabilities were $300.45M for the fiscal quarter, a -0.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.